DEFINITIVE | Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer
01-12-2023
-30-11-2028
Show more information
Organisation
WSG WESTDEUTSCHE STUDIENGRUPPE GMBH